E. L. Phelan

726 total citations
28 papers, 588 citations indexed

About

E. L. Phelan is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, E. L. Phelan has authored 28 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in E. L. Phelan's work include Birth, Development, and Health (5 papers), Hormonal Regulation and Hypertension (5 papers) and Sodium Intake and Health (4 papers). E. L. Phelan is often cited by papers focused on Birth, Development, and Health (5 papers), Hormonal Regulation and Hypertension (5 papers) and Sodium Intake and Health (4 papers). E. L. Phelan collaborates with scholars based in New Zealand, United States and Canada. E. L. Phelan's co-authors include David W. J. Clark, R. Laverty, F. O. Simpson, Alan J. Wood, F. H. Smirk, Kenneth M. Taylor, John Junginger, Katie E. Cherry, Peter Bolli and Murray R. Grigor and has published in prestigious journals such as Circulation Research, British Journal of Pharmacology and Cellular and Molecular Life Sciences.

In The Last Decade

E. L. Phelan

28 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. L. Phelan New Zealand 13 159 139 132 118 90 28 588
V.V. Frolkis Ukraine 15 222 1.4× 140 1.0× 190 1.4× 99 0.8× 72 0.8× 80 726
Herbert S. Ormsbee United States 17 232 1.5× 192 1.4× 170 1.3× 58 0.5× 47 0.5× 36 834
P Montastruc France 17 273 1.7× 241 1.7× 218 1.7× 189 1.6× 67 0.7× 148 931
T. Hedner Sweden 19 167 1.1× 272 2.0× 148 1.1× 97 0.8× 50 0.6× 34 686
M. G. Ziegler United States 11 76 0.5× 111 0.8× 79 0.6× 115 1.0× 52 0.6× 16 489
Eric H. Mills Australia 13 115 0.7× 143 1.0× 97 0.7× 129 1.1× 109 1.2× 38 493
J. L. Elghozi France 10 112 0.7× 120 0.9× 117 0.9× 274 2.3× 96 1.1× 18 585
Alphonse J. Ingenito United States 14 116 0.7× 297 2.1× 257 1.9× 80 0.7× 32 0.4× 51 564
M. J. Fregly United States 15 180 1.1× 48 0.3× 98 0.7× 107 0.9× 92 1.0× 31 422
Brody Mj United States 14 151 0.9× 140 1.0× 171 1.3× 325 2.8× 106 1.2× 24 761

Countries citing papers authored by E. L. Phelan

Since Specialization
Citations

This map shows the geographic impact of E. L. Phelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. L. Phelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. L. Phelan more than expected).

Fields of papers citing papers by E. L. Phelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. L. Phelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. L. Phelan. The network helps show where E. L. Phelan may publish in the future.

Co-authorship network of co-authors of E. L. Phelan

This figure shows the co-authorship network connecting the top 25 collaborators of E. L. Phelan. A scholar is included among the top collaborators of E. L. Phelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. L. Phelan. E. L. Phelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ledingham, Janet M., et al.. (1995). EFFECT OF FELODIPINE TREATMENT AND WITHDRAWAL ON BLOOD PRESSURE AND CARDIOVASCULAR STRUCTURE IN NEW ZEALAND GENETICALLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 22(s1). S326–8. 2 indexed citations
3.
Ledingham, Janet M., et al.. (1994). REMODELLING OF RESISTANCE ARTERIES BY TREATMENT WITH ENALAPRIL IN THE NEW ZEALAND GENETICALLY HYPERTENSIVE RAT. Clinical and Experimental Pharmacology and Physiology. 21(3). 235–237. 6 indexed citations
4.
Junginger, John, et al.. (1993). Prevalence of Psychopathology in Elderly Persons in Nursing Homes and in the Community. Psychiatric Services. 44(4). 381–383. 51 indexed citations
5.
Ledingham, Janet M., E. L. Phelan, & J. A. Millar. (1993). EFFECTS OF CILAZAPRIL ON THE STRUCTURE OF MESENTERIC RESISTANCE ARTERIES OF NEW ZEALAND GENETICALLY HYPERTENSIVE AND NORMOTENSIVE CONTROL RATS. Clinical and Experimental Pharmacology and Physiology. 20(5). 362–364. 4 indexed citations
6.
Smyth, D D, et al.. (1992). Renal α2‐adrenoceptors in New Zealand genetically hypertensive rats. Journal of Autonomic Pharmacology. 12(2). 73–80. 4 indexed citations
7.
Phelan, E. L., et al.. (1990). Sensitivity to Ca2+ and the Effects of a Calcium Channel Antagonist in Resistance Vessels from Two Strains of Genetically Hypertensive Rat. Journal of Cardiovascular Pharmacology. 16. S12–S13. 5 indexed citations
8.
9.
Simpson, F. O., J. M. Ledingham, & E. L. Phelan. (1986). Electrolytes and spontaneous genetic hypertension in rats.. PubMed. 4(3). S235–40. 1 indexed citations
10.
Simpson, F. O., et al.. (1984). Iodide excretion in a salt-restriction trial.. PubMed. 97(770). 890–3. 12 indexed citations
11.
Phelan, E. L. & David W. J. Clark. (1979). EFFECT OF CAPTOPRIL ON BLOOD PRESSURE AND VASCULAR RESISTANCE IN NORMOTENSIVE AND GENETICALLY HYPERTENSIVE RATS. The Medical Journal of Australia. 2(SP2). 4 indexed citations
12.
Wood, Alan J., E. L. Phelan, & F. O. Simpson. (1975). Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clinical and Experimental Pharmacology and Physiology. 2(4). 297–304. 54 indexed citations
13.
Bolli, Peter, et al.. (1974). Prazosin: Preliminary Clinical and Pharmacological Observations. Clinical Science. 48(s2). 177s–179s. 15 indexed citations
14.
Simpson, F. O., et al.. (1973). Studies on the New Zealand Strain of Genetically Hypertensive Rats. Clinical Science. 45(s1). 15s–21s. 10 indexed citations
15.
Heslop, Barbara F. & E. L. Phelan. (1973). The GH and AS hypertensive rat strains. Laboratory Animals. 7(1). 41–46. 10 indexed citations
16.
Clark, David W. J., R. Laverty, & E. L. Phelan. (1972). Long‐lasting peripheral and central effects of 6‐hydroxydopamine in rats. British Journal of Pharmacology. 44(2). 233–243. 137 indexed citations
17.
Phelan, E. L.. (1966). Cardiovascular reactivity in rats with spontaneous inherited hypertension and constricted renal artery hypertension. American Heart Journal. 71(1). 50–57. 15 indexed citations
18.
Smirk, F. H. & E. L. Phelan. (1965). The kidneys of rats with genetic hypertension. The Journal of Pathology and Bacteriology. 89(1). 57–62. 3 indexed citations
19.
Phelan, E. L., et al.. (1962). Observations on the Responses of Rats with Spontaneous Hypertension and Control Rats to Pressor Drugs and to Hexamethonium. Circulation Research. 10(5). 817–824. 22 indexed citations
20.
Phelan, E. L. & F. H. Smirk. (1960). Cardiac hypertrophy in genetically hypertensive rats. The Journal of Pathology and Bacteriology. 80(2). 445–448. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V.V. Frolkis Breakdown of academic impact, for papers by Herbert S. Ormsbee Breakdown of academic impact, for papers by P Montastruc Breakdown of academic impact, for papers by T. Hedner Breakdown of academic impact, for papers by M. G. Ziegler Breakdown of academic impact, for papers by Eric H. Mills Breakdown of academic impact, for papers by J. L. Elghozi Breakdown of academic impact, for papers by Alphonse J. Ingenito Breakdown of academic impact, for papers by M. J. Fregly Breakdown of academic impact, for papers by Brody Mj
Rankless by CCL
2026